Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bevacizumab and Endothelium Dependent Vasodilation

NCT01125943 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01125943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01125943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bevacizumab and Endothelium Dependent Vasodilation
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2010
Completion date
November 30, 2011
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, endothelial dysfunction, hypertension